To review what the impact of the latest oncological data shared at ASH will be, Swapnika Ramu, Scientific Editor, Cell Press will be hosting a free-to-attend panel discussion on December 15th, 2020. Tune in to:
- Discuss how non-gene edited allogeneic CAR-T therapies can maintain a strong safety profile whilst having strong clinical activity.
- Evaluate how best to demonstrate clinical efficacy for NK cells and progress through trial stages.
- Explore the heating up of the race to bring BCMA therapies to the market, and how CMC controls are being added to pass through filing
Date / Time:
Friday, January 15, 2021 -
7:00pm to 8:00pm
Categories:
Registration URL:
Call to Action Label (Upcoming):
Register Today
On-Demand Option:
Registration required
Outbound Registration URL:
On-Demand Registration is the same as the registration URL:
0
Call to Action Label (On-Demand):
View Webinar
Event Type:
Webinar Type: